SGX Nifty January 2026 futures declined by 0.50 points, suggesting a stable opening for the Nifty 50 today.
Institutional Flows:
On 13 January 2026, provisional data indicated that foreign portfolio investors (FPIs) divested shares amounting to Rs 1,499.81 crore, whereas domestic institutional investors (DIIs) recorded net purchases totaling Rs 1,181.78 crore in the Indian equity market. Foreign Institutional Investors have divested shares amounting to Rs 16,925.03 in January to date. This follows their cash sales of Rs 34,349.62 crore in December and Rs 17,500.31 crore in November.
Global Markets:
Asian markets exhibited a mixed performance, despite Japanese indexes reaching record highs on Wednesday. The recent surge in Japanese equities was driven by anticipations that Prime Minister Sanae Takaichi may initiate a snap election, potentially scheduled for February. This election marks Takaichi’s inaugural opportunity to engage with Japan’s electorate.
Overnight in the U.S., all three major indexes experienced declines as investors contended with the volatility stemming from a series of proposals recently put forth by U.S. President Donald Trump. The S&P 500 experienced a decline of 0.19% as investors opted to sell JPMorgan, despite the release of better-than-expected financial results. Meanwhile, the Dow Jones Industrial Average recorded a decrease of 0.8%. The Nasdaq Composite experienced a decline of 0.1%.
Domestic Market:
Domestic equity benchmarks concluded the trading session on Tuesday in the red, as an initial rebound lost momentum, resulting in markets being impacted by significant intraday selling and a delicate sentiment landscape. The BSE Sensex experienced a decline of up to 995 points from its intraday peak, while the Nifty 50 fell by 296 points as selling pressure escalated throughout the trading session. The Nifty, having reached an intraday peak of 25,899.80 during the initial trading session, ultimately fell beneath the 25,750 threshold by the end of the day.
Stocks in the consumer durables and pharmaceutical sectors experienced significant declines. The decline was primarily influenced by profit-taking in major stocks following the recent rally, as investors opted to secure gains in the face of uncertain global indicators. Increasing crude oil prices have intensified pressure, heightening worries regarding inflation and the current account perspective.
Continued foreign institutional selling exerted pressure on sentiment, despite strong domestic participation. The depreciation of the rupee relative to the dollar has notably suppressed risk appetite, particularly within import-sensitive sectors. From a technical standpoint, market indicators persistently signal fragile momentum, indicating constrained near-term upside and maintaining a cautious stance among traders in the face of heightened volatility. The S&P BSE Sensex declined by 250.48 points, representing a decrease of 0.30%, closing at 83,627.69. The Nifty 50 index experienced a decline of 57.95 points, equivalent to a decrease of 0.22%, closing at 25,732.30.